Bileaflet MVP Syndrome

<p>Bileaflet MVP Syndrome</p> <p>Guest: Michael J. Ackerman, M.D., Ph.D. (<a href='https://twitter.com/MJAckermanMDPhD'>@MJAckermanMDPhD</a>)</p> <p>Host: Paul A. Friedman, M.D. (<a href='https://twitter.com/drpaulfriedman'>@drpaulfriedman</a>)</p> <p>Mayo Clinic researchers looked at a 10-year experience of 1,200 patients who came to the Windland Smith Rice Genetic Heart Rhythm Clinic. The researchers found that 24 of those patients were survivors of out-of-hospital cardiac arrest. Ten of those 24 survivors — 42% — had bileaflet prolapse. That finding helped the research team identify the features of arrhythmogenic bileaflet mitral valve prolapse syndrome.</p> <p>Joining us today to discuss arrhythmogenic bileaflet mitral valve prolapse syndrome is Michael J. Ackerman, M.D., Ph.D., a pediatric cardiologist and principal investigator at the Windland Smith Rice Sudden Death Genomics Laboratory at Mayo Clinic in Rochester, Minnesota.</p> <p>Specific topics discussed:</p> <ul><li>Mitral valve prolapse versus arrhythmogenic bileaflet mitral valve prolapse syndrome</li> <li>Signs and symptoms of arrhythmogenic bileaflet mitral valve prolapse syndrome</li> <li>Characteristic findings of complex ectopy</li> <li>Work-up and next steps</li> <li>A role for MRI</li> <li>Mitral annular disjunction</li> <li>Treatment options</li> <li>A role for ablation</li> <li>A genetic condition or not?</li> </ul> <p>Connect with Mayo Clinic's Cardiovascular Continuing Medical Education online at <a href='https://cveducation.mayo.edu'>https://cveducation.mayo.edu</a> or on Twitter <a href='https://www.twitter.com/mayocliniccv'>@MayoClinicCV</a>.</p> <p>No CME credit offered for this episode.</p> <p>Podcast episode transcript found <a href='https://mcdn.podbean.com/mf/web/sikt57/P-MayoCV17_Bileaflet_MVP_Syndrome_Friedman-Ackerman_CC_Transcript_Final6alpk.pdf'>here</a>.</p>